Ridgewood Investments LLC Has $565,000 Stock Holdings in Core Laboratories Inc. (NYSE:CLB)

Ridgewood Investments LLC lifted its stake in Core Laboratories Inc. (NYSE:CLB) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,612 shares of the oil and gas company’s stock after acquiring an additional 1,428 shares during the quarter. Ridgewood Investments LLC owned approximately 0.07% of Core Laboratories worth $565,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of CLB. Commonwealth Equity Services LLC bought a new stake in Core Laboratories in the second quarter worth $297,000. Ballentine Partners LLC bought a new stake in Core Laboratories in the second quarter worth $206,000. Texas Permanent School Fund Corp boosted its holdings in Core Laboratories by 13.5% in the second quarter. Texas Permanent School Fund Corp now owns 46,100 shares of the oil and gas company’s stock worth $935,000 after purchasing an additional 5,489 shares in the last quarter. Headlands Technologies LLC bought a new stake in Core Laboratories in the second quarter worth $36,000. Finally, American Century Companies Inc. boosted its holdings in Core Laboratories by 18.7% in the second quarter. American Century Companies Inc. now owns 59,070 shares of the oil and gas company’s stock worth $1,199,000 after purchasing an additional 9,285 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Stock Performance

Shares of NYSE CLB traded down $0.26 during mid-day trading on Friday, hitting $17.94. The company had a trading volume of 57,496 shares, compared to its average volume of 243,146. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. The business’s 50-day simple moving average is $19.29 and its 200-day simple moving average is $19.61. Core Laboratories Inc. has a 12 month low of $13.82 and a 12 month high of $25.13. The firm has a market cap of $842.28 million, a P/E ratio of 27.60, a PEG ratio of 1.36 and a beta of 2.39.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million during the quarter, compared to analysts’ expectations of $134.16 million. During the same quarter last year, the company earned $0.22 earnings per share. The firm’s revenue was up 7.2% on a year-over-year basis. As a group, analysts predict that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, November 25th. Investors of record on Monday, November 4th were given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.22%. The ex-dividend date was Monday, November 4th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.15%.

Wall Street Analysts Forecast Growth

CLB has been the subject of a number of recent analyst reports. Citigroup decreased their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $17.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.